NEULAND LABORATORIES
Back to Income Statement
|
NEULAND LABORATORIES Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹283.71 | ₹202.74 | ₹233.89 | ₹127.45 | ₹49.74 |
What is the latest Earnings Per Share (EPS) of NEULAND LABORATORIES ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2026 | ₹283.71 |
| Mar2025 | ₹202.74 |
| Mar2024 | ₹233.89 |
| Mar2023 | ₹127.45 |
| Mar2022 | ₹49.74 |
How is Earnings Per Share (EPS) of NEULAND LABORATORIES Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2026 | ₹283.71 | 39.94 | |
| Mar2025 | ₹202.74 | -13.32 | |
| Mar2024 | ₹233.89 | 83.52 | |
| Mar2023 | ₹127.45 | 156.23 | |
| Mar2022 | ₹49.74 | - | |
Compare Earnings Per Share (EPS) of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹24,223.0 Cr | -3.9% | -16% | 17% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,204.0 Cr | -1% | -5.5% | 5.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹238,497.0 Cr | -2.6% | -3.9% | 38.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹170,481.0 Cr | -1.7% | -10.2% | 30.5% | Stock Analytics | |
| CIPLA | ₹108,012.0 Cr | 0.9% | -3.2% | -15.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,207.0 Cr | -0.6% | 1% | -0.1% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | -3.9% |
-16% |
17% |
| SENSEX | -1.6% |
-2.3% |
-11.5% |
You may also like the below Video Courses